Zobrazit v EDS

Prevalence of human papillomavirus detection in ovarian cancer: a meta-analysis

Uloženo v:
Podrobná bibliografie
Název: Prevalence of human papillomavirus detection in ovarian cancer: a meta-analysis
Autoři: S Cherif, Aziz Amine, Sarah Thies, Eliane T. Taube, Elena Ioana Braicu, Jalid Sehouli, Andreas M. Kaufmann
Zdroj: Eur J Clin Microbiol Infect Dis
Informace o vydavateli: Springer Science and Business Media LLC, 2021.
Rok vydání: 2021
Témata: Genotype, Epidemiology, Human Papillomavirus and Cervical Cancer Epidemiology, Immunology, Ovarian malignancy, Review, Cancer Incidence, Publication bias, 03 medical and health sciences, 0302 clinical medicine, Ovarian cancer, Health Sciences, Prevalence, Humans, Papillomaviridae, Internal medicine, Cancer, Ovarian Neoplasms, Cochrane Library, FOS: Clinical medicine, HPV prevalence, Papillomavirus Infections, Confidence interval, Medical microbiology, 3. Good health, Meta-analysis, Genomic Studies and Treatment of Ovarian Carcinoma, Reproductive Medicine, Oncology, Gynecology, Cervical cancer, Medicine, Subgroup analysis, Female, Ovarian Neoplasms/epidemiology [MeSH], Papillomaviridae/genetics [MeSH], Papillomavirus Infections/complications [MeSH], Female [MeSH], Systematic Reviews as Topic [MeSH], Humans [MeSH], Worldwide, Etiologic agent, Papillomavirus Infections/epidemiology [MeSH], Ovarian Neoplasms/virology [MeSH], Genotype [MeSH], Prevalence [MeSH], Viral-Related Cancers in Immunocompromised Patients, HPV Vaccination, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit, Systematic Reviews as Topic
Popis: We conducted a meta-analysis of published data to update and estimate the prevalence of HPV in ovarian cancer. A comprehensive literature search was performed according to the PRISMA guidelines. Eligible articles published from 1989 until 2020 by searching Web of Sciences, Pubmed, Embase, and the Cochrane Library Central databases were gathered. A pooled estimation of HPV prevalence with a 95% confidence interval (CI) was calculated based on a random effect model. Quantitative assessment of heterogeneity was explored using Cochrane test and I2. Additionally, publication bias, sensitivity, meta-regression, and subgroup analyses were also performed. Twenty-nine studies involving 2280 patients with ovarian cancer were included. The statistical heterogeneity was high (I2 = 88%, P
Druh dokumentu: Article
Other literature type
Jazyk: English
ISSN: 1435-4373
0934-9723
DOI: 10.1007/s10096-021-04282-7
DOI: 10.17169/refubium-40017
DOI: 10.60692/x12nk-gh690
DOI: 10.60692/kw7zq-ys246
Přístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s10096-021-04282-7.pdf
https://pubmed.ncbi.nlm.nih.gov/34086102
https://europepmc.org/article/MED/34086102
https://www.ncbi.nlm.nih.gov/pubmed/34086102
https://pubmed.ncbi.nlm.nih.gov/34086102/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346400
https://link.springer.com/article/10.1007/s10096-021-04282-7
https://link.springer.com/content/pdf/10.1007/s10096-021-04282-7.pdf
https://repository.publisso.de/resource/frl:6448983
Rights: CC BY
Přístupové číslo: edsair.doi.dedup.....014fad018a613e5a6299370e0d4e6feb
Databáze: OpenAIRE
Popis
Abstrakt:We conducted a meta-analysis of published data to update and estimate the prevalence of HPV in ovarian cancer. A comprehensive literature search was performed according to the PRISMA guidelines. Eligible articles published from 1989 until 2020 by searching Web of Sciences, Pubmed, Embase, and the Cochrane Library Central databases were gathered. A pooled estimation of HPV prevalence with a 95% confidence interval (CI) was calculated based on a random effect model. Quantitative assessment of heterogeneity was explored using Cochrane test and I2. Additionally, publication bias, sensitivity, meta-regression, and subgroup analyses were also performed. Twenty-nine studies involving 2280 patients with ovarian cancer were included. The statistical heterogeneity was high (I2 = 88%, P
ISSN:14354373
09349723
DOI:10.1007/s10096-021-04282-7